Cargando…
Review: Machine learning in precision pharmacotherapy of type 2 diabetes—A promising future or a glimpse of hope?
Precision pharmacotherapy of diabetes requires judicious selection of the optimal therapeutic agent for individual patients. Artificial intelligence (AI), a swiftly expanding discipline, holds substantial potential to transform current practices in diabetes diagnosis and management. This manuscript...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10541760/ https://www.ncbi.nlm.nih.gov/pubmed/37786401 http://dx.doi.org/10.1177/20552076231203879 |